SP2086 Pharmacokinetic Study in Renal Insufficiency Patients

NCT02815774 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Insufficiency

Interventions

DRUG: SP2086

Sponsor

Jiangsu HengRui Medicine Co., Ltd.